0001737368-18-000001.txt : 20180417 0001737368-18-000001.hdr.sgml : 20180417 20180416182400 ACCESSION NUMBER: 0001737368-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180417 DATE AS OF CHANGE: 20180416 EFFECTIVENESS DATE: 20180417 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Saghmos Therapeutics, Inc. CENTRAL INDEX KEY: 0001737368 IRS NUMBER: 813924586 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-310295 FILM NUMBER: 18757567 BUSINESS ADDRESS: STREET 1: 25 ALLEGRA COURT CITY: WHITE PLAINS STATE: NY ZIP: 10603 BUSINESS PHONE: 914-522-3885 MAIL ADDRESS: STREET 1: 25 ALLEGRA COURT CITY: WHITE PLAINS STATE: NY ZIP: 10603 D 1 primary_doc.xml X0708 D LIVE 0001737368 Saghmos Therapeutics, Inc. 15 East Putnam Avenue #430 Greenwich CT CONNECTICUT 06830-5424 914-522-3885 DELAWARE None None Corporation true 2016 Anna Kazanchyan c/o Saghmos Therapeutics, Inc. 15 East Putnam Avenue, #430 Greenwich CT CONNECTICUT 06830-5424 Executive Officer Shalini Cornelio c/o Saghmos Therapeutics, Inc. 15 East Putnam Avenue, #430 Greenwich CT CONNECTICUT 06830-5424 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2017-08-10 false true true false 0 7000000 3500000 3500000 false 5 0 0 0 Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering. false Saghmos Therapeutics, Inc. /s/ Anna Kazanchyan Anna Kazanchyan Chief Executive Officer 2018-04-16